Related references
Note: Only part of the references are listed.Characterization of functional domains in the Merkel cell polyoma virus Large T antigen
Roland Houben et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
T-cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients with Merkel Cell Carcinoma from Healthy Donors
Rikke Lyngaa et al.
CLINICAL CANCER RESEARCH (2014)
gamma delta T Cells and Their Potential for Immunotherapy
Yan-Ling Wu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Cells of Origin in Skin Cancer
Juergen C. Becker et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Universes Collide: Combining Immunotherapy with Targeted Therapy for Cancer
Jennifer A. Wargo et al.
CANCER DISCOVERY (2014)
Merkel Cell Carcinoma: Epidemiology, Target, and Therapy
Mathew P. Hughes et al.
CURRENT DERMATOLOGY REPORTS (2014)
Regulation of Ligands for the NKG2D Activating Receptor
David H. Raulet et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
NK cell-based immunotherapy for malignant diseases
Min Cheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Merkel Polyomavirus-Specific T Cells Fluctuate with Merkel Cell Carcinoma Burden and Express Therapeutically Targetable PD-1 and Tim-3 Exhaustion Markers
Olga K. Afanasiev et al.
CLINICAL CANCER RESEARCH (2013)
Effects of treatment with histone deacetylase inhibitors in solid tumors: a review based on 30 clinical trials
Tianzhu Qiu et al.
FUTURE ONCOLOGY (2013)
Distinct Gene Expression Profiles of Viral- and Nonviral-Associated Merkel Cell Carcinoma Revealed by Transcriptome Analysis
Paul W. Harms et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Tumor-Specific T Cells in Human Merkel Cell Carcinomas: A Possible Role for Tregs and T-Cell Exhaustion in Reducing T-Cell Responses
Mitra Dowlatshahi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
A cornucopia of human polyomaviruses
James A. DeCaprio et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Vorinostat Induces Apoptosis and Differentiation in Myeloid Malignancies: Genetic and Molecular Mechanisms
Gabriela Silva et al.
PLOS ONE (2013)
PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
Evan J. Lipson et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Type I and II IFNs Inhibit Merkel Cell Carcinoma via Modulation of the Merkel Cell Polyomavirus T Antigens
Christoph Willmes et al.
CANCER RESEARCH (2012)
An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells
Roland Houben et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects
Maria Grazia Ruocco et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Interferon-γ Up-Regulates Major-Histocompatibility-Complex Class I-Related Chain A Expression and Enhances Major-Histocompatibility-Complex Class I-Related Chain A-Mediated Cytolysis of Human Corneal Epithelium by Natural Killer Cells In Vitro
Jiaxu Hong et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2012)
MCV and Merkel cell carcinoma: a molecular success story
Reety Arora et al.
CURRENT OPINION IN VIROLOGY (2012)
Human NKG23-ligands: cell biology strategies to ensure immune recognition
Lola Fernandez-Messina et al.
FRONTIERS IN IMMUNOLOGY (2012)
Immune activation by combination human lymphokine-activated killer and dendritic cell therapy
E. J. West et al.
BRITISH JOURNAL OF CANCER (2011)
Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator
Masahiro Shuda et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival
Kelly G. Paulson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Immunobiology of Merkel Cell Carcinoma: Implications for Immunotherapy of a Polyomavirus-Associated Cancer
Shailender Bhatia et al.
CURRENT ONCOLOGY REPORTS (2011)
Histone Deacetylase Inhibitors and Mithramycin A Impact a Similar Neuroprotective Pathway at a Crossroad between Cancer and Neurodegeneration
Sama F. Sleiman et al.
PHARMACEUTICALS (2011)
The role of Sp1 and Sp3 in normal and cancer cell biology
Lin Li et al.
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2010)
Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system
Bianca D. Lemos et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens
Roland Houben et al.
JOURNAL OF VIROLOGY (2010)
NK Cells and gamma delta T Cells Mediate Resistance to Polyomavirus-Induced Tumors
Rabinarayan Mishra et al.
PLOS PATHOGENS (2010)
Why do viruses cause cancer? Highlights of the first century of human tumour virology
Patrick S. Moore et al.
NATURE REVIEWS CANCER (2010)
Spheroid-based drug screen: considerations and practical approach
Juergen Friedrich et al.
NATURE PROTOCOLS (2009)
HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer
A. Lopez-Soto et al.
ONCOGENE (2009)
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients:: the AEIOU features
Michelle Heath et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D
Noam Stern-Ginossar et al.
NATURE IMMUNOLOGY (2008)
Histone deacetylase inhibitors: Overview and perspectives
Milos Dokmanovic et al.
MOLECULAR CANCER RESEARCH (2007)
Transcriptional regulation of MICA and MICB:: A novel polymorphism in MICB promoter alters transcriptional regulation by Sp1
Sandra Rodriguez-Rodero et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B Ligands of NKG2D
Gopalakrishnan M. Venkataraman et al.
JOURNAL OF IMMUNOLOGY (2007)
FDA approval summary: Vorinostat for treatment of advanced primary cutaneous T-cell lymphoma
Bhupinder S. Mann et al.
ONCOLOGIST (2007)
Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B
S Skov et al.
CANCER RESEARCH (2005)
Cutting edge:: NKG2D is a costimulatory receptor for human naive CD8+ T cells
K Maasho et al.
JOURNAL OF IMMUNOLOGY (2005)
Merkel cell carcinoma: Changing incidence trends
NC Hodgson
JOURNAL OF SURGICAL ONCOLOGY (2005)
Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease
B Meresse et al.
IMMUNITY (2004)
NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Roles of the NKG2D immunoreceptor and its ligands
DH Raulet
NATURE REVIEWS IMMUNOLOGY (2003)
Expression of stress-induced MHC class I related chain molecules on human melanoma
CS Vetter et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
A Diefenbach et al.
NATURE (2001)
Share Paper
